Breaking News

August Bioservices Secures $65M in Funding to Expand Capacity

Will be used to add an additional sterile injectable filling suite to support high-speed liquid vial filling.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

August Bioservices, a pharmaceutical contract development and manufacturing organization (CDMO) providing drug discovery, development, and manufacturing services, secured $65 million in Series B funding led by Oak HC/FT. This round includes participation from existing investor, Polaris Partners.   The new funding will be used to expand August Bio’s capacity with an additional sterile injectable filling suite to support high-speed liquid vial filling. This expansion will add incremental c...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters